Tg Therapeutics (TGTX) EBIT Margin Growth (3y) (2020 - 2026)
Tg Therapeutics (TGTX) EBIT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Tg Therapeutics |
7.71 Bn |
7.06 Bn |
171.41 Mn |
49,105.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
49,105.00 |
| Dec 31, 2025 |
9.69 Mn |
| Sep 30, 2025 |
3.72 Mn |
| Jun 30, 2025 |
658,041.00 |
| Mar 31, 2025 |
332,420.00 |
| Dec 31, 2024 |
403,229.00 |
| Sep 30, 2024 |
420,832.00 |
| Jun 30, 2024 |
502,766.00 |
| Mar 31, 2024 |
1.12 Mn |
| Dec 31, 2023 |
22.83 Mn |
| Sep 30, 2023 |
22.57 Mn |
| Jun 30, 2023 |
13.35 Mn |
| Mar 31, 2023 |
13.17 Mn |
| Dec 31, 2022 |
297,362.00 |
| Sep 30, 2022 |
12.30 Mn |
| Jun 30, 2022 |
8.70 Mn |
| Mar 31, 2022 |
8.80 Mn |
| Dec 31, 2021 |
13.85 Mn |
| Sep 30, 2021 |
8.61 Mn |
| Jun 30, 2021 |
-12.17 Mn |
